Author: Scott Dylan
Scott Dylan
Scott Dylan is a pioneering entrepreneur from South East London, whose modest beginnings have driven his remarkable career. In 2019, he co-founded Inc & Co with a bold vision to rejuvenate struggling businesses, preserve jobs, reduce creditor losses, and promote growth. Under the stewardship of Scott, Group CEO Jack Mason, and Group CTO Dave Antrobus, Inc & Co has grown into a global force with an annual turnover exceeding £150 million. The company’s diverse portfolio includes sectors such as Professional Services, Travel, Retail, Ecommerce, and Shared Workspaces, showcasing a robust record of acquisitions and expansion. Scott's entrepreneurial acumen is further evidenced by strategic divestitures, including the sales of MyLife Digital to Dataguard and Laundrapp to Laundryheap, demonstrating his skill in amplifying business value and ensuring sustainable development. Beyond his business ventures, Scott is a passionate mental health advocate, openly discussing his experiences with Complex PTSD to aid others. He champions Women in Business and Tech and proudly represents the LGBTQ+ community, promoting diversity and inclusion in the workplace. With over two decades in leadership roles, Scott believes in the power of teamwork, fostering strong relationships, and nurturing a supportive culture as cornerstones of success. Scott Dylan's journey is characterised by resilience, collaboration, and a commitment to making a positive impact both in the business world and beyond. His dedication to creating an inclusive, empowering environment for all team members is a testament to his visionary leadership and aspirations for a brighter future.
In a shocking turn of events, Aaron Traywick, CEO of Ascendance Biomedical, was found dead in a spa in Washington DC. His sudden death has sparked numerous discussions within the biohacking community.While an autopsy is pending, authorities have ruled out foul play. The 28-year-old was well-known for his controversial self-experimentation, including injecting an unregulated herpes drug on stage, stirring debates over the ethics of biohacking.Aaron Traywick’s name became synonymous with the burgeoning field of biohacking. As CEO of Ascendance Biomedical, he was a vocal advocate for using unregulated therapies to bypass conventional drug development timelines.Traywick’s bold experiments, particularly his public…
Tinder, a pioneer in the online dating scene, finds itself amidst an unexpected challenge. Facebook’s sudden announcement of its own dating service at the F8 developer conference has raised eyebrows and questions.Amidst a turbulent period marked by the Cambridge Analytica scandal, Facebook’s timing for entering the dating arena is intriguing. Tinder’s CEO, Mandy Ginsberg, has expressed surprise at this move, which comes in a time of heightened scrutiny over privacy.Facebook’s Entry Into Online DatingThe announcement by Facebook CEO Mark Zuckerberg about launching a dating service was a surprise to many, especially to existing players like Tinder. This unexpected move by…
A groundbreaking partnership has formed in the field of nanotechnology between a renowned nanotech firm and a Nobel Prize-winning physicist. This venture aims to develop and commercialise a new generation of nano-materials, promising significant advancements across multiple industries.The collaboration brings together the resources and expertise of the Nanoco Group and Professor Novoselov from the University of Manchester. Their combined efforts are set to transform material science by scaling the production of two-dimensional nano-particles.The Genesis of a Revolutionary VentureNanoco Group, a key player in the nanotechnology industry, has embarked on an ambitious project to commercialise two-dimensional (2D) materials. These materials, merely…
Henry Birch is poised to become Shop Direct’s new CEO on 14th May, stirring significant anticipation within the digital retail sector.Currently CEO of Rank Group, Birch brings extensive experience in digital transformation, ready to elevate Shop Direct’s growth trajectory.Henry Birch to Lead Shop DirectHenry Birch, the newly appointed CEO of Shop Direct, is set to take control on Monday, 14th May. The announcement marks a significant transition within the UK’s second-largest pureplay digital retailer. This follows his successful tenure at the Rank Group plc, where he significantly boosted digital operations and profitability.Shop Direct, renowned for its digital department stores such…
Duologi is making strategic moves to enhance its operational efficiency and expand its market reach.With Giles Askham’s appointment as Director of Operations, Duologi is set to embark on a new phase of growth and innovation.Duologi, a prominent consumer lending specialist, has taken a significant step in its expansion journey by appointing Giles Askham as the new Director of Operations. This strategic move aligns with the company’s vision to scale operations rapidly over the next 12 months. With the backing of Oaktree Capital, a global investment firm, Duologi is poised to enhance its market presence by offering bespoke point-of-sale finance solutions…
A promising £500,000 investment has been made in Invizius, a forefront player in medical technology innovation. The investment underlines the importance of advancing dialysis treatment.Invizius’s pioneering research aims to enhance patient outcomes by reducing inflammation-related complications in dialysis.Pioneering Investment in Dialysis TechnologyThe significant £500,000 investment by Mercia Fund Managers in Invizius is a noteworthy development in the realm of medical technology. Such funding signifies not just financial backing but a commitment to advancing healthcare solutions. As the first investment post their University of Edinburgh partnership, it epitomises the fusion of innovative research and practical application.Invizius, a cutting-edge spin-out company, is…
AlphaBiolabs, a leading biotech firm, celebrates a remarkable year of growth. The company, famed for DNA testing services on the Jeremy Kyle Show, reports record revenues.With a notable 16% revenue increase, reaching £4.2 million, AlphaBiolabs highlights its expanding influence in DNA and drug testing services. This success underscores the firm’s reputation for reliability and innovation.AlphaBiolabs’ Milestone AchievementAlphaBiolabs, a renowned biotech firm established in 2004, is celebrating a significant milestone. The company, known for conducting DNA tests for the Jeremy Kyle Show, has seen its revenues rise by 16 percent, reaching an impressive £4.2 million. This growth marks the firm’s most…
In a significant move to expand its operations, digital education leader Tes is set to create 200 new roles, reinforcing its commitment to innovation and education.The new roles will be based in a Sheffield office, marking a pivotal expansion for Tes globally recognised for its influence in the educational sector.Sheffield: A New Hub for Education TechnologyThe choice of Sheffield as the location for Tes’ new office is strategic, leveraging its proximity to the Department of Education offices and the city’s vibrant educational ecosystem, including renowned universities and major edtech players.The establishment of this office aligns with Tes’ vision to harness…
Business Growth Fund (BGF) has strategically invested £3 million in Cardiff-based software consultancy DevOpsGuys, marking the firm’s inaugural venture in Wales. Founded in 2013, DevOpsGuys aids companies in enhancing software delivery efficiency, boasting a current revenue exceeding £7 million with a team of 63.The investment from BGF aims to facilitate ambitious expansion plans, including opening new offices and employing additional staff to augment its sales, marketing, consultancy, and engineering teams. This injection of capital is set to accelerate DevOpsGuys’ growth trajectory significantly, enabling greater service offerings and capacity.BGF’s investment marks a pivotal juncture in DevOpsGuys’ journey, fueling its expansion and…
BenevolentAI has announced a significant leadership change, appointing Joanna Shields as their new group CEO. This marks a pivotal moment for the company, known for leveraging artificial intelligence in scientific discovery.Joanna joins with immediate effect, bringing years of experience garnered from her roles in both government and major tech companies. Her appointment represents BenevolentAI’s commitment to driving innovation and expanding their influence within the industry.While the horizon seems promising, Joanna Shields will need to navigate potential challenges such as regulatory hurdles and the fast-paced evolution of AI technology.Her strategic vision and expertise will be critical in overcoming these obstacles, ensuring…
© 2025 Business Manchester